How many indolent lymphoma relapses is enough?
My history:
Oct 1996: Diagnosed and treated for nodular lymphocyte predominant Hodgkin's lymphoma* in abdomen and pelvis. NED after six cycles of ABVD.
June 2018: Diagnosed with NLPHL again, treated with Rituximab. NED
Sept 2020: Relapsed, treated with Bendamustine with Rituximab. NED
March 2023: Relapsed, treated with 4gy/2 small dose radiation. Response pending
My question: who on this board with indolent lymphoma has had 2-3 or more relapses? Did they come in quick succession like this, where lymphoma is initially responsive to treatments but ultimately resistant? If so, was there a treatment that has had a durable response for you, and if so what was it?
This question may be too specific in context of the relatively small pool of active posters on this board. But if you have experienced this, or know of someone who has, please let me know.
Thanks -- tgy
*I know the WHO has given NLPHL a different name and category now.
Comments
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.9K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 398 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 793 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 63 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 540 Sarcoma
- 732 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards